Défibrillateur automatique implantable (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Défibrillateur automatique implantable" in French language version.

refsWebsite

Global rank French rank

5nejm.org

2,374^th place

298^th place

3onlinejacc.org

low place

2,587^th place

2sciencedirect.com

149^th place

80^th place

2wiley.com

222^nd place

129^th place

2oup.com

485^th place

416^th place

2ahajournals.org

3,608^th place

659^th place

1thelancet.com

2,393^rd place

506^th place

1oxfordjournals.org

1,389^th place

508^th place

1jamanetwork.com

2,650^th place

689^th place

1ajconline.org

low place

1apodiq.com

low place

1nih.gov

4^th place

12^th place

ahajournals.org

circ.ahajournals.org

(en) Zipes DP, Camm AJ, Borggrefe M et al. « ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines » Circulation 2006;114:e385-e484

ahajournals.org

Gold MR, Lambiase PD, El-Chami MF et al. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial, Circulation, 2021;143:7–17

ajconline.org

(en) Germano JJ, Reynolds M, Essebag V, Josephson ME, « Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? » Am J Cardiol. 2006;97:1255–1261

apodiq.com

Précautions à respecter, sur le site apodiq.com

jamanetwork.com

jama.jamanetwork.com

(en) Peterson PN, Varosy PD, Heidenreich PA et al. « Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention » JAMA 2013;309:2025-2034

nejm.org

Knops RE, Olde Nordkamp LR, Delnoy PH et al. Subcutaneous or transvenous defibrillator therapy, N Engl J Med, 2020;383:526-536
Køber L, Thune JJ, Nielsen JC et al. Defibrillator implantation in patients with nonischemic systolic heart failure, N Engl J Med, 2016;375:1221-1230
Moss AJ, Schuger C, Beck CA et al. MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming, N Engl J Med, 2012;367:2275–2283

content.nejm.org

(en) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators, « Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction » N Engl J Med. 1989;321:406-412
(en) Moss AJ, Hall WJ, Cannom DS et al. « Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia » N Engl J Med. 1996;335:1933-1940

nih.gov

ncbi.nlm.nih.gov

(en) Kremers MS, Hammill SC, Berul CI et al. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011, Heart Rhythm, 2013;10:e59–e65

onlinejacc.org

content.onlinejacc.org

(en) Tung R, Zimetbaum P, Josephson ME, A Critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death, JACC, 2008;52: 1111-1121
(en) Tracy CM, Epstein AE, Darbar D et al. « 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society » J Am Coll Cardiol. 2013;61:e6-e75.
(en) Brignole M, Occhetta M, Bongiorni M, SAFE-ICD Study Investigators et al. « Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant » J Am Coll Cardiol. 2012;60:981-987

oup.com

academic.oup.com

Knops RE, Pepplinkhuizen S, Delnoy PP et al. Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial, Europ Heart J, 2022;43:4872–4883
Vijgen J, Botto G, Camm J et al. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators, Europace, 2009;11:1097–1107

oxfordjournals.org

eurheartj.oxfordjournals.org

Priori SG, Blomström-Lundqvist C, Mazzanti A et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathThe Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), Eur Heart J, 2015;36:2793-2867

sciencedirect.com

Bardy GH, Smith WM, Hood MA et al. An entirely subcutaneous implantable cardioverter-defibrillator, N Engl J Med, 2010;363:36–44
Burke MC, Gold MR, Knight BP et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry, J Am Coll Cardiol, 2015;65:1605–1615

thelancet.com

(en) Julian DG, Camm AJ, Frangin G et al. « Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT » Lancet 1997;349:667-674

wiley.com

onlinelibrary.wiley.com

(en) Healey JS, Birnie DH, Lee DS et al. « Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry » J Cardiovasc Electrophysiol. 2010;21:1344-1348
(en) Mond HG, Proclemer A, The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a World Society of Arrhythmia’s project, Pacing Clin Electrophysiol, 2011;34:1013–1027